SCHEMBL14933485

SCHEMBL14933485

O=c1c2ccccc2c2c3cccnc3ccc2n1-c1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
MAPT P10636 3/20 0.39
HSP90AA1 P07900 1/20 0.39
ACVR1 Q04771 3/20 0.37
ALDH1A1 P00352 3/20 0.36
CYP2C19 P33261 2/20 0.36
TSHR P16473 2/20 0.36
LOXL3 P58215 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36
GAA P10253 1/20 0.35
IL1B P01584 1/20 0.35
CYP2C9 P11712 1/20 0.35
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14933409 0.87 MAPK1 (0.49) KMT2AMAPTACVR1ALDH1A1CYP2C19
SCHEMBL20633744 0.86 ACVR1 (0.38) CYP1A1CYP1A2CYP1B1KMT2AMEN1
SCHEMBL14933482 0.80 MEN1 (0.41) KMT2AMEN1MAPTHSP90AA1ALDH1A1
SCHEMBL14933365 0.79 KMT2A (0.47) CYP1A2KMT2AMEN1MAPTHSP90AA1
SCHEMBL14933610 0.77 KMT2A (0.42) KMT2AMEN1MAPTHSP90AA1ALDH1A1
SCHEMBL14933515 0.76 KMT2A (0.48) CYP1A2KMT2AMEN1MAPTHSP90AA1
SCHEMBL14933410 0.74 KMT2A (0.47) CYP1A2KMT2AMEN1MAPTHSP90AA1
SCHEMBL14933341 0.74 KMT2A (0.53) CYP1A2KMT2AMEN1MAPTHSP90AA1
SCHEMBL14933402 0.74 KMT2A (0.40) KMT2AMEN1MAPTHSP90AA1ALDH1A1
SCHEMBL14933580 0.74 MAPK1 (0.41) KMT2AMEN1MAPTHSP90AA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649213-B1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-06-23 EP disclosed
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
WO-2019007867-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-01-10 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 CYP1A1 207/4885CYP1A2 170/4885CYP1B1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.